甲状腺不同术式术后早期甲状腺激素变化研究
本文选题:甲状腺结节 + 甲状腺切除术 ; 参考:《吉林大学》2016年硕士论文
【摘要】:近年来我国甲状腺结节的发病率逐年增高。手术是治疗甲状腺良恶结节的常用手段。通过动态观察甲状腺不同术式术后早期甲状腺激素的变化规律,指导甲状腺术后内分泌治疗适宜的起始时间,减少医源性并发症的发生率,提高甲状腺结节患者的术后生活质量,使甲状腺术后的内分泌治疗更加科学规范。目的:动态研究甲状腺不同术式术后早期甲状腺激素变化规律。探讨不同术式下甲状腺术后给予内分泌治疗的适宜的起始时间。方法:选取2014年1月至2015年12月期间于吉林大学第二医院甲状腺外科行手术治疗的符合选择及排除标准的患者120例。按其手术方式分为四组,单侧甲状腺次全切除术组30例,双侧甲状腺次全切除术组30例,患侧甲状腺及峡部全切除术组30例,双侧甲状腺全切除术组30例。四组患者分别采集术后第1、3、5、7、14天空腹静脉血。应用ADVIA Centaur?XP全自动免疫分析系统及配套试剂采用电化学发光免疫分析法检测相应时段血清甲状腺激素水平。其中双侧甲状腺全切除组和患侧甲状腺及峡部全切除组60名患者术后病理证实为恶性。结果:对比观察120例患者术前及术后早期检测的甲状腺激素水平变化。甲状腺全切除术组术后血清tt3、ft3逐渐下降,于术后第5天略有升高,后再逐渐下降,但术后各时间点测得结果与术前比较均低于术前(p0.05);血清tt4、ft4术后第1天呈一过性上升趋势,后逐渐下降,术后第5天明显低于术前(p0.05),术后第7天降至正常低值附近,术后第14天明显低于正常低值(p0.05);血清tsh术后第1天呈一过性下降,后逐渐上升,于术后第3天明显高于术前(p0.05),术后第5天超过正常值高限,后继续升高。患侧甲状腺腺叶全切及峡部全切除术组血清tt3、ft3术后第1天、术后第3天一过性下降,术后第5天开始逐渐上升,术后各个时间点测得血清tt3、ft3值低于术前水平(p0.05);血清tt4、ft4术后第1天一过性升高,明显高于术前(p0.05),之后逐渐下降,于术后第14天降到正常低值附近;血清tsh术后第1天一过性下降,明显低于术前(p0.05),后逐渐上升,于术后第7天明显高于术前(p0.05),术后第14天明显超出正常值高值。双侧甲状腺次全切除术组血清tt3、ft3术后逐渐下降,术后第7天明显低于术前(p0.05),低于正常参考值下限,后逐渐上升,术后第14天与术前无明显差异(p0.05);血清tt4、ft4术后第1天术后第1天一过性升高,明显高于术前(p0.05),后逐渐下降,术后第14天明显低于术前(p0.05),血清tt4降到正常值低限附近,血清ft4低于正常值低限;血清tsh术后一过性下降,明显低于术前(p0.05),之后逐渐上升,术后第7天明显高于术前(p0.05),高于正常值高限。单侧甲状腺次全切除组血清TT3、FT3术后一过性下降,术后第3天明显低于术前(P0.05),后逐渐上升,术后第14天仍低于术前;血清TT4、FT4术后第1天一过性升高,明显高于术前(P0.05),后逐渐下降,术后第7天明显低于术前(P0.05),后逐渐上升,血清TT4术后14天与术前无明显差异(P0.05);血清TSH术后第1天一过性下降,明显低于术前(P0.05),后逐渐升高,第7天明显高于术前,后逐渐下降,术后第14天仍高于术前,但未超过正常值高值。结论:甲状腺不同术式术后早期甲状腺激素呈动态变化,且变化趋势不同;根据甲状腺手术切除范围的不同,术后早期血循环中甲状腺激素变化趋势不同,给予外源性甲状腺激素替代治疗及TSH抑制治疗的起始时间不同。单侧甲状腺切除术切除术后剩余甲状腺代偿功能较好,可在术后一个月内给予相对少量或不给予外源性甲状腺激素替代治疗;双侧甲状腺次全切除术后剩余甲状腺代偿功能不良,可在术后14左右给予外源性甲状腺激素替代治疗;双侧甲状腺全切除术后,可在术后第5天左右给予外源性甲状腺激素行TSH抑制治疗;患侧甲状腺及峡部全切除术后,可在术后第14天左右给予外源性甲状腺激素行TSH抑制治疗。因存在个体差异,所有患者应根据相应时间的甲状腺激素水平制定个体化的治疗方案。
[Abstract]:In recent years, the incidence of thyroid nodules in China is increasing year by year. Surgery is a common means for the treatment of thyroid benign and malignant nodules. Through dynamic observation of the changes in the early thyroid hormone after different thyroidectomy, the appropriate starting time of endocrine therapy after thyroid surgery is guided, the incidence of iatrogenic complications is reduced, and the thyroid is improved. The postoperative quality of life of the patients with nodules makes the endocrine treatment more scientific after thyroid surgery. Objective: to dynamically study the changes in the early thyroid hormone changes after different thyroidectomy. The appropriate starting time for the treatment of endocrine therapy after different surgical thyroidectomy was discussed. Methods: from January 2014 to December 2015. In the second hospital of Jilin University, 120 cases of surgical treatment of thyroid surgery were divided into four groups, 30 cases with unilateral subtotal thyroidectomy, 30 cases of bilateral thyroidectomy, 30 cases of lateral thyroid and isthmus resection, 30 cases of bilateral total thyroidectomy. Four groups of patients. The blood of the 1,3,5,7,14 sky abdominal vein was collected after the operation. The serum thyroid hormone levels were detected by the ADVIA Centaur? XP automatic immunoassay system and the auxiliary reagents by electrochemiluminescence immunoassay. 60 patients with bilateral thyroid total excision group and the affected side thyroid and isthmus total excision group were treated after surgical pathology. Results: the changes of thyroid hormone levels were observed in 120 patients before and after the operation. The serum TT3, FT3 decreased gradually after the total thyroidectomy group, slightly increased at the fifth day after the operation, and then decreased gradually, but the results were lower than before the operation (P0.05) after the operation (P0.05); serum TT4, FT4 after operation. The 1 day showed an upward trend, then decreased gradually, after fifth days obviously lower than before operation (P0.05), seventh days after the operation to the normal low value, fourteenth days after the operation was significantly lower than the normal low value (P0.05), the serum TSH after first days after a sexual decline, the third days after the operation was significantly higher than before the operation (P0.05), fifth days after the operation was higher than the normal value higher after the operation. Blood serum TT3, first days after FT3, first days after operation, third days after operation, first days after operation, and a gradual rise in fifth days after operation, and the serum level of FT3 was lower than that before operation (P0.05) at every time point after operation, and the serum TT4, FT4 after the operation was higher than that of preoperative (P0.05). After the operation, it descended to the normal low value fourteenth days after the operation, and the first days after the operation of serum TSH decreased obviously, obviously lower than that before operation (P0.05), and then increased gradually, at seventh days after the operation (P0.05), and fourteenth days after the operation. The serum of bilateral thyroid gland subtotal excision group was TT3, FT3 was gradually decreased after operation, seventh after operation. The day was lower than the preoperative (P0.05), lower than the normal reference value, and then increased gradually, and there was no significant difference between the fourteenth days after the operation (P0.05). Serum TT4, first days after the operation, first days after the operation increased, obviously higher than before (P0.05), then gradually decreased, fourteenth days after the operation (P0.05), serum TT4 dropped to the normal value of the low limit, serum, near the normal value of the low limit, serum, near the normal value of the low limit of serum, serum FT4 was lower than normal value, and the serum TSH decreased significantly after operation, which was obviously lower than before operation (P0.05), and then increased gradually. The seventh day after operation was significantly higher than that before operation (P0.05), higher than normal value. The serum TT3, FT3 after unilateral subtotal thyroidectomy group decreased after operation, and was significantly lower than before operation (P0.05) after operation (P0.05), and fourteenth days after the operation, The level of serum TT4 and FT4 increased first days after operation, which was significantly higher than before operation (P0.05), then decreased gradually, after seventh days obviously lower than before operation (P0.05), and then gradually increased, and there was no significant difference between 14 days after TT4 operation (P0.05) after the operation of serum TT4, and first days after TSH in serum decreased significantly, obviously lower than before (P0.05), and then gradually increased, seventh days obviously. It was higher than before the operation, and then decreased gradually, fourteenth days after the operation was still higher than the preoperative, but not higher than the normal value. Conclusion: thyroid hormone in different stages of thyroid surgery has a dynamic change, and the change trend is different. According to the different range of thyroidectomy, the change trend of thyroid hormone in the blood circulation in the early post operation is different, giving exogenous nail The initial time of the replacement therapy of adenoidectomy and TSH inhibition is different. The residual thyroid compensatory function is better after unilateral thyroidectomy, and a relatively small amount or no exogenous thyroid hormone replacement therapy can be given within one month after the operation; the residual thyroid compensatory function after bilateral thyroidectomy is poor. Exogenous thyroid hormone replacement therapy was given about 14 postoperatively, and exogenous thyroid hormones could be treated with TSH inhibition after fifth days after bilateral thyroidectomy, and exogenous thyroid hormones could be treated with TSH inhibition after fourteenth days after total resection of the affected thyroid and isthmus. All patients should develop individualized treatment based on thyroid hormone levels at the corresponding time.
【学位授予单位】:吉林大学
【学位级别】:硕士
【学位授予年份】:2016
【分类号】:R653
【相似文献】
相关期刊论文 前10条
1 张祥盛,朱玉红;甲状腺郎格汉斯组织细胞增生症[J];中华内分泌代谢杂志;2003年02期
2 施秉银;甲状腺结节和肿瘤研究进展——第七届亚洲和大洋洲甲状腺会议侧记[J];国外医学.内分泌学分册;2004年03期
3 徐立勤,胡春燕;原发性干燥综合征合并甲状腺功能异常的临床研究[J];浙江预防医学;2005年08期
4 王琨;陈祖培;;碘与甲状腺功能及其相关疾病[J];中国地方病学杂志;2006年03期
5 王旭;文万信;;碘-131治疗甲状腺功能亢进症及甲状腺质量测量[J];中国辐射卫生;2008年04期
6 刘诗川;谷云有;;碘与硒对甲状腺功能影响的研究进展[J];中国地方病防治杂志;2012年06期
7 谷秀莲;窦京涛;;药源性甲状腺功能异常[J];药品评价;2013年15期
8 ;49例甲状腺结节扫描结果分析(附病理对照)[J];铁道医学;1977年05期
9 Kaлинин АП и лру ,刘书明;自身免疫性甲状腺炎的诊断[J];国外医学.内分泌学分册;1989年02期
10 李宜华;1例罕见的黑色甲状腺[J];国外医学.内分泌学分册;1990年02期
相关会议论文 前10条
1 吴洁;;甲状腺功能异常与不孕[A];妇科内分泌与辅助生殖论坛论文集[C];2011年
2 阎玉芹;房辉;项建梅;陈祖培;;碘缺乏与碘过多对大鼠碘代谢、甲状腺功能及甲肿形成的影响[A];中华医学会第六次全国内分泌学术会议论文汇编[C];2001年
3 覃伟武;谢永双;;~(131)I治疗Graves病疗效的影响因素[A];第二届全国核素显像及治疗学术会议论文摘要汇编[C];2004年
4 李涛;马西;;微囊甲状腺细胞移植治疗甲状腺功能低下研究[A];天津市生物医学工程学会2004年年会论文集[C];2005年
5 黄国良;高妍;;Graves病患者甲状腺内H202生成异常[A];2008内分泌代谢性疾病系列研讨会暨中青年英文论坛论文汇编[C];2008年
6 魏薇;桑仲娜;赵娜;张桂芹;谭龙;陈雯;张万起;;不同碘水平地区成人甲状腺自身免疫状态的研究[A];营养与老年代谢病——达能营养中心第十四届学术年会论文集[C];2011年
7 王玉华;李妍;李亚明;李艳梅;尹雅芙;李雪娜;李娜;;不同浓度高碘饮食对小鼠甲状腺摄锝功能影响的实验研究[A];中国核科学技术进展报告——中国核学会2009年学术年会论文集(第一卷·第9册)[C];2009年
8 滕晓春;单忠艳;滕卫平;范晨玲;王红;郭锐;;碘过量对NOD.H-2h4小鼠甲状腺功能、形态和甲状腺自身免疫影响的实验研究[A];2008内分泌代谢性疾病系列研讨会暨中青年英文论坛论文汇编[C];2008年
9 蔡鹄;赵家军;高聆;;薯蓣皂苷元对Ad-TSHR-289诱导Graves'病模型小鼠甲状腺细胞增殖的抑制作用[A];中华医学会第十二次全国内分泌学学术会议论文汇编[C];2013年
10 周新建;张政;齐磊;刘洋;连宇;;低剂量及常规剂量~(131)I治疗小甲状腺Graves病的疗效观察[A];第三届全国核素显像暨核素治疗学术交流会论文汇编[C];2006年
相关重要报纸文章 前10条
1 本报记者 李颖;关心甲状腺 保护身体发动机[N];科技日报;2010年
2 复旦大学附属眼耳鼻喉科医院耳鼻喉科教授 周 梁;“脸红脖子粗”不是小事[N];解放日报;2003年
3 主任医师 容小翔;碘剂会致癌吗[N];卫生与生活报;2007年
4 以颇;甲状腺功能减退 早发现早治疗[N];保健时报;2005年
5 湖北省人民医院核医学科 陈辉霖;亚急性甲状腺炎与甲状腺机能亢进症[N];健康报;2000年
6 陆维巧;甲状腺怎会有“冷、凉、温、热”[N];大众卫生报;2004年
7 本报记者 王雪敏;桥本甲状腺炎,拒绝“一刀切”[N];医药经济报;2011年
8 尤国;甲亢的手术治疗[N];医药经济报;2010年
9 姜晓华 赵咏桔;甲状腺相关眼病缓解症状是关键[N];健康报;2006年
10 核工业415医院 陈再君;碘~131为何能治甲亢[N];大众卫生报;2002年
相关博士学位论文 前10条
1 毛小荣;中国汉族人群HCV感染与IL-28基因多态性及甲状腺功能相关性研究[D];兰州大学;2015年
2 邵珊珊;脂毒性致甲状腺功能异常的机制研究[D];山东大学;2015年
3 金萍;1型糖尿病与甲状腺自身免疫的关联及其预测研究[D];中南大学;2009年
4 钟霞;VEGF、IGF-1、bFGF与Graves病患者甲状腺内血管形成及甲状腺体积关系的研究[D];山东大学;2005年
5 王琨;碘缺乏与碘过量对甲状腺功能的影响及其调控机制的研究[D];天津医科大学;2007年
6 桑仲娜;碘过量对不同人群甲状腺功能影响及成人碘安全摄入量的研究[D];天津医科大学;2011年
7 黄惠斌;碘对甲状腺滤泡功能的调控作用及分子机制研究[D];福建医科大学;2010年
8 杨继金;Graves病甲状腺的血供分析及动脉栓塞治疗[D];第二军医大学;2004年
9 佟雅洁;碘过量对甲状腺功能及脱碘酶活性的影响[D];中国医科大学;2005年
10 蔡鹄;薯蓣皂苷元对Ad-TSHR-289诱导Graves病模型小鼠甲状腺细胞增殖及免疫功能的影响[D];山东大学;2013年
相关硕士学位论文 前10条
1 王莉云;TPO-Ab、TSH与体外受精—胚胎移植结局关系的研究[D];新乡医学院;2014年
2 欧科鹏;绵羊甲状腺中褪黑素的合成及其生理作用的研究[D];石河子大学;2015年
3 李红梅;肿瘤放疗对甲状腺功能损伤的研究[D];泰山医学院;2014年
4 卢懿;新诊断2型糖尿病患者甲状腺功能状态临床观察[D];河北医科大学;2015年
5 蒋宇婷;原发性肾病综合征伴甲状腺激素水平异常的临床分析[D];兰州大学;2015年
6 王越;甲状腺24hRAIU与~(131)I治疗Graves甲亢疗效相关性研究[D];山西医科大学;2015年
7 章阳;聊城地区碘与甲状腺常见疾病相关性研究[D];山东大学;2015年
8 张福彬;TFF3和Clorf24在甲状腺细针穿刺甲状腺滤泡型肿瘤组织中的差异性表达及其意[D];南京大学;2014年
9 何光晴;住院2型糖尿病患者甲状腺功能状况及甲减对糖尿病慢性并发症、合并症的影响[D];昆明医科大学;2015年
10 排孜丽亚·买提阿西木;2型糖尿病患者甲状腺功能指标状况分析[D];兰州大学;2015年
,本文编号:1949767
本文链接:https://www.wllwen.com/yixuelunwen/waikelunwen/1949767.html